Forbion
@ForbionLifeSci
Followers
245
Following
148
Statuses
125
Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies that transform people’s lives.
Joined September 2021
We are thrilled to announce our latest fundraise of over €2 Billion across two new funds! Check out the details: #LifeSciences #VentureCapital #Forbion #biotech
0
4
9
Forbion proudly backs Purespring Therapeutics. Read more about this latest series B financing: #seriesB #lifesciences #biotech #financing
0
1
2
0
1
2
Our second investment announcement from the Forbion BioEconomy Fund in 2 days. Welcome Novameat! Read more here: #lifesciences #bioeconomy #biotech #VC
0
1
1
Read more about our latest investment in Navigator Medicines #lifesciences #financing #seriesA #forbion
0
2
2
0
1
1
Catch up on the news of the series D financing of our portfolio company Catalym. #seriesD #lifesciences #biotech
0
2
1
Just in: Forbion leads $170 M Series B Funding in Beacon Therapeutics #seriesB #financing #lifesciences #biotech #forbion
0
1
3
RT @statnews: Exclusive: Forbion, a European venture capital firm that manages around $3 billion, has recruited former Dyne Therapeutics CE…
0
2
0
0
1
1
Excited to announce the first close of Forbion BioEconomy Fund I at €75M! This new fund invests in biotech solutions for Food, Agriculture, Materials, and Environmental Tech. #VentureCapital #Biotech #Sustainability #Forbion #BioEconomy
1
1
3
News from the Forbion Ventures Fund. Read more about our investment in Marea Tx. #biotech #lifesciences #cardionmetabolic
0
1
0
Episode 4 of The Biotech Pulse is out now. If you want to learn more about the role of biotech as a discovery engine for pharma in research and development, then this is the episode for you. #biotech #lifesciences #venturecapital #CEO #CTO
0
0
1
Proud to announce the $1.25 Billion Sale to Johnson & Johnson of our portfolio company Numab Therapeutics Subsidiary. #lifesciences #biotech #biotechnology
0
3
6
Read more about our participation in the $555m financing of Bicycle Therapeutics. #financing #lifesciences #biotech #venturecapital #impactonpatients
0
1
1
We are proud to announce our newest investment in Progentos Therapeutics. Forbion led the $65M series A round with General Partner Dmitrij Hristodorov and Sr Assoc Marc-Olivier Turgeon joining Progentos' board. #biotech
0
0
0
0
0
0
Our 5th exit in just about a year. Congratulations team Forbion! #lifesciences #biotech @endpts #oncology
1
2
5
Read more about the latest announcement from our portfolio company Synox #portfolionews #lifesciences #bitoech
0
1
1
Read about the new appointments at Seamless Therapeutics #career #portfoliocompany #lifesciences #bitoech
0
0
0